What is a common recommendation for patients experiencing sexual dysfunction from SSRIs?

Patients experiencing sexual dysfunction as a side effect of selective serotonin reuptake inhibitors (SSRIs) often have the option to add an adjunct medication to their current treatment plan. This approach is commonly recommended because certain medications, such as bupropion or sildenafil, can help alleviate sexual side effects without compromising the efficacy of the SSRI.

Switching to antipsychotics is not typically a recommended strategy for managing SSRIs-related sexual dysfunction, as antipsychotics can also have sexual side effects and may complicate the patient's overall psychiatric treatment. Increasing the SSRI dose is unlikely to resolve sexual dysfunction and could potentially exacerbate it, making such a move counterproductive. Reducing exercise would not be beneficial, as regular physical activity is generally linked to improved sexual health and mood, and reducing exercise could lead to further negative effects on a patient's overall well-being.

Thus, the addition of an appropriate adjunct medication is a practical and evidence-based approach to address the issue of sexual dysfunction caused by SSRIs, highlighting the importance of a tailored and comprehensive treatment plan.